Related Experiment Videos
[Vascular disorders and obstructive sleep apnea syndrome]
1Clinique Neurologique, CHU La Milétrie, 86021 Poitiers. jph.neau@chu-poitiers.fr
Revue Neurologique
|April 2, 2002
Summary
Obstructive sleep apnoea syndrome (OSAS) is a significant risk factor for stroke and other vascular diseases. Early screening for OSAS in patients with acute vascular events is recommended to improve outcomes.
Area of Science:
- Cardiology
- Neurology
- Sleep Medicine
Context:
- Obstructive sleep apnoea syndrome (OSAS) is increasingly recognized as a significant independent risk factor for major vascular diseases, including stroke, coronary artery disease, and hypertension.
- Studies indicate a high prevalence of OSAS (70-95%) in patients presenting with acute stroke.
- The presence of OSAS in stroke patients is associated with poorer clinical outcomes.
Purpose:
- To review the evidence linking OSAS to vascular diseases, particularly stroke.
- To discuss the potential pathophysiological mechanisms connecting OSAS and stroke.
- To emphasize the importance of screening for OSAS in patients with acute vascular events.
Summary:
- OSAS is an independent risk factor for stroke, coronary artery diseases, and hypertension.
- Potential mechanisms include arterial hypertension, cardiac arrhythmia, atherogenesis, coagulation disorders, and altered cerebral metabolism/hemodynamics.
- Systematic screening for OSAS is advised in patients with acute vascular events.
Impact:
- Highlights the critical role of OSAS in vascular disease pathogenesis.
- Supports the integration of OSAS screening into the management of acute vascular events.
- Underscores the need for further research into optimal treatment timing for OSAS in this population.